Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 22, 2013

View Archived Issues

Novel lung cancer-related gene fusions associated with oncogenic potential and drug-sensitivity

Tensha Therapeutics begins trial of BET bromodomain inhibitor TEN-010

Kyowa Hakko Kirin begins international phase III study of istradefylline

Phase II results for CSL-112 as a potential treatment for atherothrombotic disease

PaxVax initiates phase I trial to investigate two adenovirus anthrax vector candidate vaccines

Myriad Genetics forms second HRD test collaboration with BioMarin

Abilify Maintena approved in E.U. for maintenance treatment of schizophrenia

DSR-85955 as a new mineralocorticoid receptor antagonist

MPO inhibitor PF-1355 demonstrates significant attenuation of cardiovascular and renal disorders

Oncolytics Biotech reports topline data from Reolysin study in head and neck cancer

AstraZeneca presents a potent, novel progesterone receptor antagonist

Yale University presents novel antibody recruiting molecules for cancer

Researchers at Pfizer synthesize novel BACE1/2 inhibitors for Alzheimer's disease

Preclinical combinatorial kinase inhibition of genetic mutation-based cancer growth

Merck & Co. synthesizes new CETP inhibitors

Spirogen and UCL Business disclose new agents for bacterial infections

Vivione Biosciences enters into CRADA to expand the capability of RAPID-B

Arrayit enters agreement with Diagnostic Oncology Research Organization

DM-1992 shows promising plasma concentration-time profiles in phase II trials

Onoact 50 approved in Japan for new indication

New phase I/II study to explore trametinib and palbociclib for melanoma

Capricor Therapeutics formed through merger of Capricor and Nile Therapeutics

Avastin approved in Japan for ovarian cancer

Non-small cell lung cancer treatment Xalkori receives regular FDA approval

Eylea approved in Japan for macular edema secondary to central retinal vein occlusion

Paxil tablets approved for post-traumatic stress disorder in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...